Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists

The invention relates to benzimidazole-carboxamide 5-HT4 receptor agonist compounds of formula (I)wherein R1 and X are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The invention also relates to pharmaceutical compositions comprising such...

Full description

Saved in:
Bibliographic Details
Main Author McKinnell, Robert Murray
Format Patent
LanguageEnglish
Published 30.06.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention relates to benzimidazole-carboxamide 5-HT4 receptor agonist compounds of formula (I)wherein R1 and X are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The invention also relates to pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
AbstractList The invention relates to benzimidazole-carboxamide 5-HT4 receptor agonist compounds of formula (I)wherein R1 and X are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The invention also relates to pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
Author McKinnell, Robert Murray
Author_xml – fullname: McKinnell, Robert Murray
BookMark eNrjYmDJy89L5WSwc0rNq8rMzUxJrMrPSdVNTixKyq9IBPJTFZLzcwvyS_NSihUSixVMdT1CTBSKUpNTC0ryixQS0_PzMotLinkYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSXxosKGBmaWZmamZk5ExMWoAackyaA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Physics
ExternalDocumentID US10696656B2
GroupedDBID EVB
ID FETCH-epo_espacenet_US10696656B23
IEDL.DBID EVB
IngestDate Fri Jul 19 13:59:45 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US10696656B23
Notes Application Number: US201916260984
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200630&DB=EPODOC&CC=US&NR=10696656B2
ParticipantIDs epo_espacenet_US10696656B2
PublicationCentury 2000
PublicationDate 20200630
PublicationDateYYYYMMDD 2020-06-30
PublicationDate_xml – month: 06
  year: 2020
  text: 20200630
  day: 30
PublicationDecade 2020
PublicationYear 2020
RelatedCompanies THERAVANCE BIOPHARMA R&D IP, LLC
RelatedCompanies_xml – name: THERAVANCE BIOPHARMA R&D IP, LLC
Score 3.2688775
Snippet The invention relates to benzimidazole-carboxamide 5-HT4 receptor agonist compounds of formula (I)wherein R1 and X are as defined in the specification, or a...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
METALLURGY
ORGANIC CHEMISTRY
PHYSICS
TESTING
Title Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200630&DB=EPODOC&locale=&CC=US&NR=10696656B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LSwMxEB5Kfd50VbQ-iCB7C9LtJtVDFfZRitAHdld6K9ltViq6W5oVpb_eSWytFz3kkARCMjCPL5n5AnBVT9kt-iFJGUYL1OVM0BtHNinP0BdnnDUSoYuTuz3eid2HERtV4GVVC2N4Qj8MOSJqVIr6Xhp7PVtfYgUmt1JdJ1McKu7bUSuwl-jYMRRSduC1wkE_6Pu277fiod17xFiXY2DPuIfmekOH0ZpnP3zydFXK7LdLae_B5gBXy8t9qMjcgh1_9fOaBdvd5YO3BVsmQzNVOLjUQnUAd57MF9O36UQsildJUzFPik-BfUl0hrj-KEkRoQijncglaNLkDJE1Ec-FpslVh3DZDiO_Q3FL45_zj-PheveNI6jmRS6PgUwykTaadYcjynQdVyYTBDuIMLBliWjyE6j9vU7tv8lT2NWy_E6LO4NqOX-X5-h7y-TCCO0LFx6HwQ
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD6MeZlvOhWdtwrStyDrmlQfqtB2o-puuE72NtIulYm2Y60o-_WexM75og95SAIhOXAuX3LOF4CLekSv0Q8JQjFaICajnFwZwiIsRl8cM9oIuSxO7nSZPzTvR3RUgpdlLYziCf1Q5IioURHqe67s9Wx1ieWp3MrsMpziUHrbCmxPL9CxoSikdM-xm_2e13N117WHA737iLEuw8CeMgfN9Zol2Xll6PTkyKqU2W-X0tqG9T6uluQ7UBJJFSru8ue1Kmx2igfvKmyoDM0ow8FCC7NduHFEspi-TSd8kb4KEvF5mH5y7AtNZojLj5IyjWcaJX5gamjSxAyRtcafU0mTm-3BeasZuD7BLY1_zj8eDla7b-xDOUkTcQDaJOZRw6obDFGmaZginCDYQYSBLQ65xQ6h9vc6tf8mz6DiB532uH3XfTiCLSnX7xS5Yyjn83dxgn44D0-VAL8AmVyKrg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Benzimidazole-carboxamide+compounds+as+5-HT4+receptor+agonists&rft.inventor=McKinnell%2C+Robert+Murray&rft.date=2020-06-30&rft.externalDBID=B2&rft.externalDocID=US10696656B2